Global Blood Screening Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Global blood screening market is expected to reach with a healthy CAGR of 9.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
- In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.
- In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.
- In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today’s world. The Blood screening method is found to be more useful for detecting cancer.
- In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.
- Enzo Biochem Inc.
- Meridian Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- BD
- bioMérieux SA
- Beckman Coulter, Inc.
- Abbott
- F. Hoffmann-La Roche Ltd
- Cepheid
- Grifols
- Seimens AG
- Ortho Clinical Diagnostics
- Immucor, Inc.
- Hologic Inc.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 GLOBAL BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 GLOBAL BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 SWITZERLAND
10.3.7 NETHERLANDS
10.3.8 BELGIUM
10.3.9 RUSSIA
10.3.10 TURKEY
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 SINGAPORE
10.4.6 AUSTRALIA
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 REST OF SOUTH AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 SOUTH AFRICA
10.6.2 REST OF MIDDLE EAST & AFRICA
11 GLOBAL BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 GLOBAL BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 GLOBAL BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 SWITZERLAND
10.3.7 NETHERLANDS
10.3.8 BELGIUM
10.3.9 RUSSIA
10.3.10 TURKEY
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 SINGAPORE
10.4.6 AUSTRALIA
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 REST OF SOUTH AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 SOUTH AFRICA
10.6.2 REST OF MIDDLE EAST & AFRICA
11 GLOBAL BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
LIST OF FIGURES
Figure 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF
GLOBAL BLOOD SCREENING MARKET
Figure 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITable REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017
Figure 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017)
Figure 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025)
Figure 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018 - 2025)
Figure 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017)
Figure 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025)
Figure 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017)
Figure 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025)
Figure 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
LIST OF FIGURES
Figure 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF
GLOBAL BLOOD SCREENING MARKET
Figure 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITable REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017
Figure 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017)
Figure 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025)
Figure 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018 - 2025)
Figure 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017)
Figure 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025)
Figure 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017)
Figure 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025)
Figure 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF
GLOBAL BLOOD SCREENING MARKET
Figure 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITable REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017
Figure 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017)
Figure 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025)
Figure 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018 - 2025)
Figure 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017)
Figure 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025)
Figure 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017)
Figure 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025)
Figure 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
LIST OF FIGURES
Figure 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF
GLOBAL BLOOD SCREENING MARKET
Figure 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITable REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017
Figure 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017)
Figure 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025)
Figure 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018 - 2025)
Figure 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017)
Figure 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025)
Figure 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025)
Figure 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
(2018 TO 2025)
Figure 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017)
Figure 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025)
Figure 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025)
Figure 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
